Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus

The patient was a 73-year-old woman with lung adenocarcinoma and systemic lupus erythematosus (SLE) who was treated with pembrolizumab. After six cycles of pembrolizumab, she developed symptoms suggestive of neuropsychiatric SLE, such as resting tremor, confusional state, depression, mood disorder,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jono, Misato, Kinehara, Yuhei, Utsu, Yoshihiko, Tamura, Yoshiro, Koseto, Masahiro, Murakami, Teruaki, Uota, Akifumi, Ninomiya, Ryusuke, Komo, Satoshi, Sumitani, Satoru, Sato, Bunzo, Kasayama, Soji, Tachibana, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056375/
https://www.ncbi.nlm.nih.gov/pubmed/31666468
http://dx.doi.org/10.2169/internalmedicine.3782-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056375/
https://www.ncbi.nlm.nih.gov/pubmed/31666468
http://dx.doi.org/10.2169/internalmedicine.3782-19

Ejemplares similares